Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CAEP Cantor Equity Partners III	$10.37 +0.2%	$0.00	$10.30 ▼ $11.09	$363.78M	N/A	178,134 shs	60,603 shs
DMAA Drugs Made In America Acquisition	$10.25 -0.1%	$0.00	$9.95 ▼ $10.28	$299.00M	N/A	96,334 shs	41,402 shs
EVY Eaton Vance New York Municipal Income Trust	$15.17 +0.1%	$15.18	$12.69 ▼ $15.30	$81.95M	0.16	13,036 shs	28,100 shs
OACC Oaktree Acquisition Corp. III Life Sciences	$10.44 -0.1%	$10.45	$9.95 ▼ $10.85	$234.07M	N/A	101,608 shs	59,269 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CAEP Cantor Equity Partners III	0.00%	-0.67%	-2.45%	+1,034,999,900.00%	+1,034,999,900.00%
DMAA Drugs Made In America Acquisition	0.00%	0.00%	-0.10%	+1,025,999,900.00%	+1,025,999,900.00%
EVY Eaton Vance New York Municipal Income Trust	0.00%	0.00%	0.00%	0.00%	0.00%
OACC Oaktree Acquisition Corp. III Life Sciences	+0.10%	+0.58%	-0.19%	+0.10%	+1,044,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CAEP Cantor Equity Partners III	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DMAA Drugs Made In America Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EVY Eaton Vance New York Municipal Income Trust	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
CAEP Cantor Equity Partners III	N/A	N/A	N/A
DMAA Drugs Made In America Acquisition	N/A	N/A	N/A
EVY Eaton Vance New York Municipal Income Trust	N/A	N/A	N/A
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CAEP Cantor Equity Partners III	N/A	N/A	N/A	N/A	N/A	N/A
DMAA Drugs Made In America Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
EVY Eaton Vance New York Municipal Income Trust	N/A	N/A	N/A	N/A	N/A	N/A
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CAEP Cantor Equity Partners III	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A
DMAA Drugs Made In America Acquisition	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A
EVY Eaton Vance New York Municipal Income Trust	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CAEP Cantor Equity Partners III	N/A	N/A	N/A	N/A	N/A
DMAA Drugs Made In America Acquisition	N/A	N/A	N/A	N/A	N/A
EVY Eaton Vance New York Municipal Income Trust	$0.55	3.63%	N/A	N/A	N/A
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CAEP Cantor Equity Partners III	N/A
DMAA Drugs Made In America Acquisition	N/A
EVY Eaton Vance New York Municipal Income Trust	17.98%
OACC Oaktree Acquisition Corp. III Life Sciences	N/A

Insider Ownership

Company	Insider Ownership
CAEP Cantor Equity Partners III	N/A
DMAA Drugs Made In America Acquisition	N/A
EVY Eaton Vance New York Municipal Income Trust	1.00%
OACC Oaktree Acquisition Corp. III Life Sciences	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CAEP Cantor Equity Partners III	2	35.08 million	N/A	N/A
DMAA Drugs Made In America Acquisition	2	29.17 million	N/A	N/A
EVY Eaton Vance New York Municipal Income Trust	N/A	5.40 million	N/A	Not Optionable
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	22.42 million	N/A	N/A

EVY, CAEP, DMAA, and OACC Headlines

Recent News About These Companies

HighTower Advisors LLC Purchases New Stake in Oaktree Acquisition Corp. III Life Sciences $OACC

August 28 at 3:37 AM | marketbeat.com

Kepos Capital LP Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

August 15, 2025 | marketbeat.com

Mizuho Securities USA LLC Purchases New Holdings in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

August 13, 2025 | marketbeat.com

Picton Mahoney Asset Management Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

August 1, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVY, CAEP, DMAA, and OACC Company Descriptions

Cantor Equity Partners III NASDAQ:CAEP

$10.37 +0.02 (+0.19%)

As of 03:53 PM Eastern

We are a blank check company incorporated on November 11, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any discussions, directly or indirectly, with any business combination target regarding an initial business combination with our company. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including the financial services, digital assets, healthcare, real estate services, technology and software industries. Further, our efforts to identify a prospective target business will not be limited to any characteristics, although we expect to favor potential target companies with certain characteristics which include, but are not limited to, positive long term growth prospects, competitive advantages, consolidation opportunities, recurring revenue or the potential for recurring revenue, opportunities for operational improvement and attractive margins or the potential for attractive margins. Our executive offices are located New York, New York.

Drugs Made In America Acquisition NASDAQ:DMAA

$10.25 -0.01 (-0.10%)

As of 02:45 PM Eastern

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.

Eaton Vance New York Municipal Income Trust NYSE:EVY

Eaton Vance New York Municipal Income Trust operates as closed-end management investment Company. Its investment objective is to provide a high level of current income. The company was founded on January 29, 1999 and is headquartered in Boston, MA.

Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC

$10.44 -0.01 (-0.10%)

As of 02:33 PM Eastern

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time